This observation suggested that in CTEPH patients the decrease of IFNγ+ or IL-4+ CD4+ T cells was not associated with a concomitant decrease or increase in IL-17-producing CD4+ T cells. This evidence concerns the gene IL17A and chronic thromboembolic pulmonary hypertension.